Alpha-glucosidase inhibitors (AGI) are classic hypoglycemic agents and one of the recommended combination therapies in the 2020 edition of the Chinese T2DM prevention and treatment guidelines. AGI drugs have been widely used in China for nearly 30 years. Based on the increasingly rich clinical applications and scientific research evidence, the Endocrinology and Metabolism Branch of … Read more
What does the α-glucosidase inhibitor look like in your eyes? Alpha-glucosidase inhibitors (AGIs) are commonly used hypoglycemic drugs in clinical practice, but what kind of hypoglycemic drug are they, and what are the differences between different AGIs? Let’s explore together today. Members of the Alpha-Glucosidase Inhibitor Family[1] Common AGIs include Acarbose, Voglibose, and Miglitol. Let’s … Read more
α-glucosidase inhibitors (AGI) are classic hypoglycemic agents and are one of the recommended combination therapies in the Chinese T2DM prevention and treatment guidelines (2020 edition). AGI drugs have been widely used in China for nearly 30 years, based on their increasingly rich clinical applications and scientific research evidence. The Endocrine and Metabolism Branch of the … Read more
*For reference by medical professionals only Will You Choose α-Glucosidase Inhibitors? Look Again Written by｜Gao Lili α-Glucosidase inhibitors (AGI) are commonly used clinically, such as Acarbose, Miglitol, and Voglibose. They inhibit the activity of intestinal α-glucosidase, thereby inhibiting carbohydrate breakdown, delaying carbohydrate absorption, reducing glucose production and absorption, lowering postprandial blood glucose (PPG), effectively reducing … Read more